- Home
- OPRX
as 05-08-2025 4:00pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Upcoming Earnings Alert:
Get ready for potential market movements as OptimizeRx Corporation OPRX prepares to release earnings report on 12 May 2025.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 154.9M | IPO Year: | N/A |
| Target Price: | $9.06 | AVG Volume (30 days): | 155.8K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.78 - $14.13 | Next Earning Date: | 05-12-2025 |
| Revenue: | $92,127,000 | Revenue Growth: | 28.81% |
| Revenue Growth (this year): | 12.12% | Revenue Growth (next year): | 10.87% |
Stock Insider Trading Activity of OptimizeRx Corporation (OPRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lang James Paul | OPRX | Director | Mar 14 '25 | Buy | $7.60 | 321,408 | $2,443,761.45 | 389,452 |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
GlobeNewswire
16 days ago
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
GlobeNewswire
20 days ago
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
Simply Wall St.
a month ago
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company
MT Newswires
a month ago
OptimizeRx Files $75 Million Mixed Shelf
Insider Monkey
2 months ago
Why OptimizeRx Corp. (OPRX) Soared Last Week?
Simply Wall St.
2 months ago
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
2 months ago
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.